ImmuPharma makes progress with Phase III trial of Lupus drug 1 234 567

ImmuPharma makes progress with Phase III trial of Lupus drug

livecharts.co.uk

Biotech company ImmuPharma said Phase III clinical trials of its Lupus treatment, Lupuzor, continued to progress on track and time, with all patients in the study having passed the nine-month stage and 116 patients completing the full 12 months.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567